StonvexLoading…
StonvexStonvexStonvexCore line items from FSTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $121.14M | $540.01M | $379.64M | $241.35M |
Operating Income | $2.04M | $21.89M | $14.05M | $5.75M |
Net Income | $1.50M | $7.54M | $5.13M | $775.00K |
EPS (Diluted) | $0.14 | $0.69 | $0.47 | $0.07 |
Total Assets | $333.78M | $330.37M | $333.89M | $349.93M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.99M | $4.35M | $3.43M | $4.19M |
Free Cash Flow OCF − CapEx | $-13.40M | $25.20M | $5.39M | $-20.98M |
Shares Outstanding | 10.33M | 10.14M | 10.25M | 10.43M |